Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
June 30, 2003
Primary Completion Date
April 30, 2006
Study Completion Date
December 31, 2009
Conditions
Breast Cancer
Interventions
DRUG
edotecarin
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00070031 - Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy | Biotech Hunter | Biotech Hunter